DE68920648D1 - Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin. - Google Patents

Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.

Info

Publication number
DE68920648D1
DE68920648D1 DE68920648T DE68920648T DE68920648D1 DE 68920648 D1 DE68920648 D1 DE 68920648D1 DE 68920648 T DE68920648 T DE 68920648T DE 68920648 T DE68920648 T DE 68920648T DE 68920648 D1 DE68920648 D1 DE 68920648D1
Authority
DE
Germany
Prior art keywords
beta
arabinofuranosyl
anhydro
thymine
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68920648T
Other languages
English (en)
Other versions
DE68920648T2 (de
Inventor
Charles William Murtiashaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE68920648D1 publication Critical patent/DE68920648D1/de
Publication of DE68920648T2 publication Critical patent/DE68920648T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/09—Pyrimidine radicals with arabinosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE68920648T 1988-07-12 1989-07-05 Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin. Expired - Fee Related DE68920648T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/217,906 US5008384A (en) 1988-07-12 1988-07-12 Process for the production of O.sup. 2,2'-anhydro-1-(β-D-arabinofuranosyl)thymine

Publications (2)

Publication Number Publication Date
DE68920648D1 true DE68920648D1 (de) 1995-03-02
DE68920648T2 DE68920648T2 (de) 1995-05-18

Family

ID=22812966

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68920648T Expired - Fee Related DE68920648T2 (de) 1988-07-12 1989-07-05 Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.

Country Status (21)

Country Link
US (1) US5008384A (de)
EP (1) EP0351126B1 (de)
JP (1) JPH075626B2 (de)
KR (1) KR910008112B1 (de)
CN (1) CN1039423A (de)
AT (1) ATE117314T1 (de)
AU (1) AU603042B2 (de)
CA (1) CA1315776C (de)
DD (2) DD284024A5 (de)
DE (1) DE68920648T2 (de)
DK (1) DK342189A (de)
ES (1) ES2066853T3 (de)
FI (1) FI893364A (de)
GR (1) GR3015293T3 (de)
HU (1) HUT50843A (de)
IE (1) IE65735B1 (de)
IL (1) IL90884A0 (de)
NO (1) NO892821L (de)
PT (1) PT91113B (de)
YU (1) YU138789A (de)
ZA (1) ZA895259B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3065350B2 (ja) * 1990-11-30 2000-07-17 ヤマサ醤油株式会社 １―（２，３―ジデオキシ―β―Ｄ―グリセロ―ペント―２―エノフラノシル）チミンの製造法
DE69415506T2 (de) * 1994-05-20 1999-08-12 Council Scient Ind Res Verfahren zur Herstellung von Beta-Thymidine
DE60144573D1 (de) 2000-11-29 2011-06-16 Mitsui Chemicals Inc Verfahren und Zwischenprodukte bei der Synthese von L-Thymidin
WO2002079213A1 (en) * 2001-03-30 2002-10-10 Triangle Pharmaceuticals, Inc. Process for the preparation of 2'-halo-$g(b)-l-arabinofuranosyl nucleosides
DE10216426A1 (de) * 2002-04-12 2003-10-23 Boehringer Ingelheim Pharma Verfahren zur Herstellung von beta-L-2'Deoxy-Thymidin
US7595390B2 (en) 2003-04-28 2009-09-29 Novartis Ag Industrially scalable nucleoside synthesis
RU2361875C2 (ru) 2003-06-30 2009-07-20 Айденикс (Кайман) Лимитед СИНТЕЗ β-L-2'-ДЕЗОКСИНУКЛЕОЗИДОВ
CA2643748A1 (en) 2006-03-15 2007-09-20 Novartis Ag Process for preparing l-nucleic acid derivatives and intermediates thereof
JP5504179B2 (ja) 2008-03-03 2014-05-28 トスク インコーポレーティッド 毒性を低減するためのメトトレキセートアジュバントおよびその使用法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3322747A (en) * 1965-04-01 1967-05-30 Merck & Co Inc Thionocarbonate nucleosides
US3463850A (en) * 1967-01-03 1969-08-26 Merck & Co Inc Arabinofuranosyl 2-thiopyrimidines and pharmaceutical compositions thereof
US3658788A (en) * 1969-06-06 1972-04-25 Salk Inst For Biological Studi Aminooxazolines and products thereof and processes for synthesizing same
US3792040A (en) * 1970-03-19 1974-02-12 Syntex Corp Acyl derivatives of o2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosines and methods of preparing
US3812098A (en) * 1970-03-19 1974-05-21 Syntex Inc O2,2'-anhydro-1-(beta-d-arabinofuranosyl)-cytosine derivatives and methods of making and related procedures
US3709874A (en) * 1970-03-19 1973-01-09 Syntex Corp 1-beta-d-arabinofuranosyl cytosine derivatives and methods of preparing
US3920630A (en) * 1970-09-24 1975-11-18 Upjohn Co 2,2{40 -Anhydro-ara-cytidine compounds and process of preparation
SE391183B (sv) * 1971-04-15 1977-02-07 Asahi Chemical Ind 2',3'-0-sulfinylcytidin och syraadditionssalter derav till anvendning som mellanprodukt for framstellning av 2,2'-anhydro-(1-beta-d-arabinofuranosyl) cytosin
US3978042A (en) * 1975-01-31 1976-08-31 The Upjohn Company Process for preparing cyclocytidine derivatives
US4140850A (en) * 1977-08-29 1979-02-20 The Upjohn Company 2,2'-Anhydrotriazine nucleosides and process for preparing the same
JPS5649398A (en) * 1979-09-28 1981-05-02 Yamasa Shoyu Co Ltd Preparation of 1-beta-d-arabinofuranosyl-2,2'-cyclothymine
JPS636557A (ja) * 1986-06-26 1988-01-12 Sharp Corp 微細パタ−ン形成方法

Also Published As

Publication number Publication date
IE892233L (en) 1990-01-12
ES2066853T3 (es) 1995-03-16
DK342189A (da) 1990-01-15
NO892821D0 (no) 1989-07-07
EP0351126A2 (de) 1990-01-17
JPH075626B2 (ja) 1995-01-25
CA1315776C (en) 1993-04-06
AU603042B2 (en) 1990-11-01
DE68920648T2 (de) 1995-05-18
DK342189D0 (da) 1989-07-11
PT91113A (pt) 1990-02-08
IE65735B1 (en) 1995-11-15
JPH0259598A (ja) 1990-02-28
PT91113B (pt) 1995-01-31
EP0351126A3 (en) 1990-10-24
AU3802089A (en) 1990-04-26
CN1039423A (zh) 1990-02-07
YU138789A (en) 1990-12-31
ATE117314T1 (de) 1995-02-15
KR910008112B1 (ko) 1991-10-10
IL90884A0 (en) 1990-02-09
FI893364A0 (fi) 1989-07-11
KR900001704A (ko) 1990-02-27
GR3015293T3 (en) 1995-06-30
NO892821L (no) 1990-01-15
HUT50843A (en) 1990-03-28
DD284024A5 (de) 1990-10-31
FI893364A (fi) 1990-01-13
US5008384A (en) 1991-04-16
EP0351126B1 (de) 1995-01-18
ZA895259B (en) 1991-02-27
DD292003A5 (de) 1991-07-18

Similar Documents

Publication Publication Date Title
ATE67497T1 (de) Verfahren zur herstellung von thiazolidinedionderivaten.
DE3681810D1 (de) Verfahren zur biotechnologischen herstellung von optisch aktiven alpha-arylalkansaeuren.
ATE47138T1 (de) Verfahren zur herstellung von 1,2-dithiolan-3pentans|ure (thioctsaeure).
DE68920648T2 (de) Verfahren zur Herstellung von O2,2'-anhydro-1-(beta-D-arabinofuranosyl)Thymin.
DK288287A (da) Heterocycliske forbindelser samt farmaceutiske praeparater til behandling af allergiske eller inflammatoriske tilstande
ATE62483T1 (de) N-alkylierung von dihydrolysergsaeure.
ATE82292T1 (de) Verfahren zur herstellung von 2-alpha-methyl-2beta-(1,2,3-triazol-1-yl)methylpenam-3-alphacarbons|urederivaten.
DE3850240D1 (de) Verfahren zur Herstellung von O-Carboxyarylimidazolinone.
DE3889772T2 (de) Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden.
DK627587D0 (da) Fremgangsmaade til fremstilling af 2-arylprpionsyrer og mikroorganismer anvendt ved denne fremgangsmaade
ATE63109T1 (de) Verfahren zur herstellung von isothiazolonen.
DE69410073D1 (de) Verfahren zur Herstellung von 2-Perfluoroalkyl-3-oxazolin-5-one
DE3780616D1 (de) Verfahren zur herstellung eines 2-alkyl- oder 2-phenyl-1,4,5,6-tetrahydropyrimidins und verfahren zur herstellung von 2-alkyl- oder 2-phenyl-pyrimidinen.
DE3851783D1 (de) Verfahren zur Herstellung von 6-[D(-)-alpha-(4-Äthyl-2,3-dioxo-1-piperazin-carboxamido)-phenylacetamido]penicillansäure.
ATE86257T1 (de) Verfahren zur herstellung von thiazolobenzimidazolen und zwischenprodukte.
DE3788369D1 (de) Verfahren zur Herstellung von Cephalosporinderivaten.
DE69105607D1 (de) Verfahren zur Herstellung von cyclischen Ketonen.
ATE46145T1 (de) Verfahren zur herstellung von 2-isocyanato-2,3dehydrocarbon-saeureestern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee